Watts Water Technologies, Inc. (WTS) Is At $80.45 Formed Wedge; Profile of 3 Analysts Covering Collagen Solutions plc (LON:COS)

Watts Water Technologies, Inc. (WTS) formed wedge up with $87.69 target or 9.00% above today’s $80.45 share price. Watts Water Technologies, Inc. (WTS) has $2.75B valuation. The stock increased 0.88% or $0.7 during the last trading session, reaching $80.45. About 117,086 shares traded. Watts Water Technologies, Inc. (NYSE:WTS) has risen 15.50% since February 2, 2017 and is uptrending. It has underperformed by 1.20% the S&P500.

Among 3 analysts covering Collagen Solutions (LON:COS), 3 have Buy rating, 0 Sell and 0 Hold. Therefore 100% are positive. Collagen Solutions had 8 analyst reports since September 16, 2015 according to SRatingsIntel. Beaufort Securities maintained the stock with “Buy” rating in Tuesday, July 12 report. The stock has “Buy” rating by Panmure Gordon on Thursday, October 13. The stock of Collagen Solutions plc (LON:COS) has “Buy” rating given on Wednesday, November 18 by Panmure Gordon. Panmure Gordon maintained it with “Buy” rating and GBX 10 target in Monday, July 11 report. The firm has “Buy” rating given on Thursday, September 15 by Panmure Gordon. The firm has “Buy” rating by Cenkos given on Tuesday, July 11. As per Wednesday, September 16, the company rating was maintained by Panmure Gordon. The stock of Collagen Solutions plc (LON:COS) earned “Speculative Buy” rating by Beaufort Securities on Tuesday, December 20. See Collagen Solutions plc (LON:COS) latest ratings:

Collagen Solutions plc develops, manufactures, and supplies medical grade collagen components and biomaterials for use in regenerative medicines, medical devices, and in-vitro diagnostics in Europe, the Middle East, Africa, North America, and Asia. The company has market cap of 8.76 million GBP. It offers collagen solubles, powders, fibrillars, gels, sheets, sponges, matrices, and other products for use in tissue matrices for medical and surgical support devices, including dental, orthopedic, hemostatic, and other applications; Bovine Pericardium is used in bio-prosthetic heart valves, dural closures, bone and dental membranes, and surgical buttressing applications; and BSE-free bovine biomaterials. It currently has negative earnings. The firm also provides product development and contract manufacturing services for collagen products.

The stock increased 8.00% or GBX 0.2 during the last trading session, reaching GBX 2.7. About 194,056 shares traded. Collagen Solutions plc (LON:COS) has 0.00% since February 2, 2017 and is . It has underperformed by 16.70% the S&P500.

Analysts await Watts Water Technologies, Inc. (NYSE:WTS) to report earnings on February, 8. They expect $0.73 EPS, up 14.06% or $0.09 from last year’s $0.64 per share. WTS’s profit will be $24.93M for 27.55 P/E if the $0.73 EPS becomes a reality. After $0.80 actual EPS reported by Watts Water Technologies, Inc. for the previous quarter, Wall Street now forecasts -8.75% negative EPS growth.

Since August 25, 2017, it had 0 buys, and 2 insider sales for $1.37 million activity. Pagano Robert J Jr sold $1.16 million worth of stock. Melhem Elie sold $205,323 worth of Watts Water Technologies, Inc. (NYSE:WTS) on Friday, August 25.